文献速递神经肿瘤

5-氨基乙酰丙酸荧光引导手术治疗复发性高级别胶质瘤

5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas.
PubMed 文献 · J Neurooncol · 2018-08-10

本综述依据PRISMA指南,汇总5-氨基乙酰丙酸(5-ALA)荧光引导手术用于复发性高级别胶质瘤(HGG)的证据。术中强荧光信号与复发性HGG肿瘤细胞存在高度相关,阳性预测值高;假阴性可见于肿瘤细胞不发荧光时,假阳性荧光信号在复发性HGG中较原发者更常见,但多为反应性/退变性组织,切除 unlikely 导致功能缺损。5-ALA安全性在原发与复发性HGG中相似。作者认为5-ALA荧光引导手术是复发性HGG切除的有力辅助手段,常规使用该荧光剂作为标准治疗是作者的观点。

要点

  • 术中强荧光信号与复发性HGG细胞肿瘤存在高度相关,阳性预测值高。
  • 复发性HGG中假阳性荧光信号较原发者更常见,但多为反应性/退变性组织。
  • 5-ALA安全性在原发与复发性HGG中相似,作者观点为常规用作标准治疗。

核心结论

  • 5-ALA荧光引导手术是复发性HGG切除的有力辅助手段,具有高阳性预测值和良好的安全性。
  • 作者认为应常规使用该荧光剂作为标准治疗。

研究设计与样本

  • 本综述按PRISMA指南制备,旨在向神经外科界强调5-ALA用于复发性HGG手术的证据。

主要发现

  • 术中强荧光信号与复发性HGG细胞肿瘤存在高度相关,赋予其高阳性预测值。
  • 与原发HGG手术相似,若肿瘤细胞不发射荧光,可出现假阴性结果。
  • 复发性HGG中无肿瘤细胞组织出现假阳性荧光信号较原发者更常见,但这些区域绝大多数含反应性/退变性组织,切除 unlikely 导致功能缺损。
  • 5-ALA的安全性在原发与复发性HGG中相似且良好。

临床怎么用

  • 作者认为应常规使用5-ALA荧光引导手术作为复发性HGG切除的标准治疗。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Fluorescence guided surgery (FGS) with five-aminolevulinic acid (5-ALA) is expected to revolutionize neurosurgical care of patients with high-grade gliomas (HGG). After the recent landmark FDA approval, this optical agent is now available to neurosurgeons in the United States. METHODS: This review is designed to highlight the evidence for the use of 5-ALA in recurrent HGG surgery for the neurosurgical community. The manuscript was prepared in accordance with the PRISMA guidelines. RESULTS: Intra-operatively, a strong fluorescent signal is highly correlated with the presence of cellular tumor in recurrent HGG, giving it a high positive predictive value (PPV). Similar to what is observed in primary HGG surgery, false-negative results can occur if tumor cells do not emit fluorescence. In addition, false-positive fluorescence signals in tissues devoid of tumor cells can be observed more frequently in recurrent HGG compared to the primary setting. However, these areas overwhelmingly contain reactive/regressive tissue, resection of which is unlikely to cause functional deficits. The safety profile of 5-ALA is similarly favorable in primary and recurrent HGG. CONCLUSIONS: 5-ALA FGS is a powerful adjunct in the resection of recurrent HGG with a high PPV and favorable safety profile. It is therefore the authors' opinion to routinely employ this fluorescent agent as a standard of care.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Chohan MO, Berger MS. 5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas. J Neurooncol. 2018. PMID: 30097823. doi:10.1007/s11060-018-2956-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。